Cetuximab (C225) is a monoclonal antibody targeting the human epidermal growth factor receptor (EGFR) with high affinity (Kd=0.201 nM). It inhibits tumor cell proliferation and induces apoptosis, making it a key tool for in vitro and in vivo cancer research, particularly in studying EGFR-driven oncology models.
Concentration:
5.62 mg/mL
Molecular Weight:
152 kDa
Purity:
>99.99% (May vary between batches)
CAS Number:
[205923-56-4]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted